PolyAurum is a pre-clinical stage biotechnology company focused on developing and commercializing biodegradable gold nanoparticles (BGNP) for diagnostic and therapeutic indications including cancer. Enhancement of radiotherapy with BNGPs has the potential to increase cancer-free survival and improve patient quality of life.